FROM THE NEWS FEED
Psilocybin falls into a regulatory gray zone, with strict limitations around how it can be studied. As a result, very little is known about its health risks, despite its surging popularity.
Continue to the original publication for the complete article.
KEEP EXPLORING
We’re seeing what happens when consumer demand collides with commercial interests for drugs including GLP-1s, psyched...
In Trip Reports, journalist Rich Haridy (a self-confessed ‘psychonaut’) dives into the science of psychedelic medicin...
Psilocybin could be an unexpected avenue for treating an injury that currently has few options beyond rest and sympto...
Psychedelics are no magic wand or silver bullet. However, in partnership with talk therapy, physical therapy, and oth...
Here’s what first time journeyers are saying about their psychedelic experience, in partnership with Psychedelic Pass...
Here’s what first time journeyers are saying about their psychedelic experience, in partnership with Psychedelic Pass...
There are many factors that can affect your journey, from set and setting to substance and dosage. At Psychedelic Pas...
Personal growth is a lifelong process. We've heard from so many people that, after years of other avenues, a psychede...
Again and again, we find that psychedelics can be the missing element that help people to heal and recover from past ...